학술논문
Safety and efficacy of bexarotene in patients with relapsing-remitting multiple sclerosis (CCMR One): a randomised, double-blind, placebo-controlled, parallel-group, phase 2a study
Document Type
Article
Author
Brown, J.W.L.; Cunniffe, N.G.; Jones, J.L.; Needham, E.; Georgieva, Z.; Michell, A.W.; Franklin, R.J.M.; Coles, A.J.; Moran, C.; Flynn, P.D.; Prados, F.; Kanber, B.; MacManus, D.; Samson, R.S.; Stutters, J.; Gandini Wheeler-Kingshott, C.A.M.; Chard, D.T.; Rog, D.; Pearson, O.R.; Overell, J.; ffrench-Constant, C.; Chandran, S.; Connick, P.; Altmann, D.R.
Source
In: The Lancet Neurology . (The Lancet Neurology, September 2021, 20(9):709-720)
Subject
Language
English
ISSN
14744465
14744422
14744422